Computed tomography of chest and Transthoracic ultrasound for Assessment of Covid -19 Pneumonia

Authors

  • Amany Fawzy Moursy, Ahmed Mohamed Saied, Nagwan Adel Ismail, Mohammed Zakria Mohamed Mosa Author

DOI:

https://doi.org/10.48047/cq9fqn03

Keywords:

Computed tomography , Transthoracic ultrasound , Covid -19 Pneumonia

Abstract

The cell receptor of COVID-19 is angiotensin-converting enzyme-2 (ACV2). COVID-19 starts as interstitial pneumonitis and then affects lung parenchyma. A wide variety of CT findings in COVID-19 have been reported in the different studies, and the CT findings differ according to the stage of the disease and disease severity and associated co-morbidities

Downloads

Download data is not yet available.

References

Pan Y, Guan H, Zhou S, et al. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. Eur Radiol. 2020;30(6):3306-9. 2. Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis treated with glucocorticoid and

human immunoglobulin. Eur Heart J. 2021;42(2):206-206

Downloads

Published

2025-01-10

How to Cite

Computed tomography of chest and Transthoracic ultrasound for Assessment of Covid -19 Pneumonia (Amany Fawzy Moursy, Ahmed Mohamed Saied, Nagwan Adel Ismail, Mohammed Zakria Mohamed Mosa , Trans.). (2025). Cuestiones De Fisioterapia, 54(2), 4724-4739. https://doi.org/10.48047/cq9fqn03